E Fund Management Co. Ltd. acquired a new stake in McKesson Co. (NYSE:MCK – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 496 shares of the company’s stock, valued at approximately $230,000.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. OFI Invest Asset Management purchased a new position in McKesson during the third quarter worth about $26,000. BKM Wealth Management LLC purchased a new position in shares of McKesson during the 4th quarter worth $31,000. WASHINGTON TRUST Co increased its position in shares of McKesson by 42.5% during the 4th quarter. WASHINGTON TRUST Co now owns 114 shares of the company’s stock worth $53,000 after purchasing an additional 34 shares during the last quarter. Milestone Investment Advisors LLC purchased a new stake in McKesson in the 3rd quarter valued at about $61,000. Finally, Orion Capital Management LLC acquired a new position in McKesson in the third quarter valued at about $63,000. Hedge funds and other institutional investors own 85.07% of the company’s stock.
Analysts Set New Price Targets
Several research firms have recently commented on MCK. Wells Fargo & Company raised their price target on McKesson from $502.00 to $551.00 and gave the stock an “equal weight” rating in a research report on Thursday. Argus lifted their target price on McKesson from $510.00 to $570.00 and gave the company a “buy” rating in a research report on Wednesday, April 10th. Leerink Partnrs reissued an “outperform” rating on shares of McKesson in a research report on Monday, February 26th. TD Cowen lifted their price objective on shares of McKesson from $563.00 to $652.00 and gave the company a “buy” rating in a report on Wednesday. Finally, Barclays raised their price target on shares of McKesson from $571.00 to $596.00 and gave the company an “overweight” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $571.47.
Insider Buying and Selling at McKesson
In other news, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction dated Friday, March 15th. The shares were sold at an average price of $524.55, for a total value of $1,821,762.15. Following the sale, the chief executive officer now owns 43,445 shares of the company’s stock, valued at $22,789,074.75. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In other news, EVP Leann B. Smith sold 186 shares of the firm’s stock in a transaction that occurred on Tuesday, February 13th. The stock was sold at an average price of $496.00, for a total value of $92,256.00. Following the completion of the sale, the executive vice president now directly owns 1,511 shares of the company’s stock, valued at approximately $749,456. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Brian S. Tyler sold 3,473 shares of McKesson stock in a transaction that occurred on Friday, March 15th. The shares were sold at an average price of $524.55, for a total value of $1,821,762.15. Following the completion of the sale, the chief executive officer now owns 43,445 shares in the company, valued at $22,789,074.75. The disclosure for this sale can be found here. 0.21% of the stock is currently owned by corporate insiders.
McKesson Trading Up 2.1 %
Shares of MCK opened at $555.12 on Friday. The company’s 50 day simple moving average is $531.56 and its 200-day simple moving average is $494.15. McKesson Co. has a 12-month low of $373.28 and a 12-month high of $566.01. The firm has a market cap of $72.95 billion, a PE ratio of 24.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.45.
McKesson (NYSE:MCK – Get Free Report) last announced its earnings results on Tuesday, May 7th. The company reported $6.18 EPS for the quarter, missing analysts’ consensus estimates of $6.34 by ($0.16). The business had revenue of $76.36 billion during the quarter, compared to analysts’ expectations of $79.32 billion. McKesson had a net margin of 0.99% and a negative return on equity of 262.63%. McKesson’s quarterly revenue was up 10.8% on a year-over-year basis. During the same period in the previous year, the company posted $7.19 earnings per share. As a group, equities research analysts forecast that McKesson Co. will post 27.59 EPS for the current fiscal year.
McKesson Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 1st. Investors of record on Monday, June 3rd will be given a $0.62 dividend. The ex-dividend date is Friday, May 31st. This represents a $2.48 dividend on an annualized basis and a yield of 0.45%. McKesson’s dividend payout ratio (DPR) is 11.08%.
McKesson Profile
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Recommended Stories
- Five stocks we like better than McKesson
- Buy P&G Now, Before It Sets A New All-Time High
- JFrog Stock Gets Punished for Solid Results: Buy the Dip
- Investing in large cap stocks: Diving into big caps
- Will the Surge in GameStop Stock Spark a New Meme Craze?
- Investing In Automotive Stocks
- 3 Stocks Nancy Pelosi Has Been Buying
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK – Free Report).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.